NCT02481297
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,003 public trials
2,033 recruiting studies
Immunoproliferative Disorders trial results
NCT01159028
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +22 more
- Locations
-
- M. D. Anderson Cancer Center Houston, Texas, United States
NCT02528838
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Completed
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
NCT01109069
- Conditions
- B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
- Locations
-
- Stanford University Stanford, California, United States
- Stanford, California, United States
- University of Chicago Chicago, Illinois, United States
- Boston, Massachusetts, United States
NCT02948413
- Conditions
- Adenoma, Genital Diseases, Genital Diseases, Male, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT02974868
- Conditions
- Alopecia, Alopecia Areata, Hair Diseases, +13 more
- Locations
-
- University of Alabama at Birmingham, Dermatology at the Whitaker Clinic Birmingham, Alabama, United States
- University of Alabama at Birmingham, The Kirklin Clinic Birmingham, Alabama, United States
- Southern California Dermatology, Inc. Santa Ana, California, United States
- Clinical Science Institute Santa Monica, California, United States
NCT02779283
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01196520
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
- Locations
-
- Bugando Medical Center Mwanza, Tanzania
- Shirati Health, Educational, and Development Foundation Shirati, Tanzania
- St.Mary's Hospital Lacor Gulu, Uganda
- Kuluva Hospital (Arua) Kampala, Uganda
NCT02504190
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Mohamad Mohty Paris, France
Completed
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
NCT03027284
- Conditions
- Adenocarcinoma, Advanced Cancer, Biliary Tract Carcinoma, +27 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan